Axovant's Nightmare Week Continues After CEO Admits Numbers Were Even Worse Than Reported Yesterday
Vivek Ramaswamy's Axovant has egg on its face after it was forced to own up to the fact it misreported mid-stage data on a drug it hoped to take into…